Projected Stock Price
No data available.
Projected Revenue
No data available.
Projected Earnings Per Share
No data available.
Price Target
Update Frequency: Monthly
Record Date | Projection Date | High | Low | Median | Average |
---|---|---|---|---|---|
2023-03-27 | 2024-03-27 | 1.05 | 1.01 | 1.02 | 1.02 |
Stock Upgrades/Downgrades
This card shows analyst upgrades/downgrades for Endo International plc. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.
The standard analyst ratings are generally as follows:- Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
- Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
- Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.
When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.
The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.
In addition to being able to interpret financial data, stock analysts have connections within the companies they cover that give them access to information retail investors do not have.
Therefore, analyst ratings can help you find opportunities in the market. However, they are guidelines more than recommendations. This is why it’s important to look at analyst ratings over a period of time.
If analysts change their ratings frequently, you should pay close attention to the company’s fundamentals. For example, has there been a significant change to the company’s earnings growth and/or debt?
You should also pay attention to the number of analysts covering a stock over the course of a year. In general, the more analysts who cover the stock give the consensus rating more credibility, but each individual rating less overall weight.
Analyst ratings are one data point for you to consider. Here are some strategies you can use to fine tune your research.
Look at more than one analyst and don’t hesitate to look at analysts that have differing views. This can help challenge any preconceived ideas you have about a stock and point out ways in which your thesis for owning or avoiding a stock may have changed.
Compare a stock’s rating with other stocks in its industry or sector. In some cases, a stock is simply superior to others in its sector. However, at other times, it could be overvalued based on investor sentiment instead of fundamentals.
How are the Fintel Analyst Ratings different?Analyst ratings by Fintel are presented in close to real-time to stay ahead of generalized information flow. Combined with target price estimates and revenue estimates for the company you have greater accuracy despite market volatility.
Date | Analyst | Prior | Latest Recommendation |
Action |
---|---|---|---|---|
2022-05-09 | BMO Capital | Market Perform | Maintains | |
2022-05-09 | Barclays | Underweight | Maintains | |
2022-03-09 | Citigroup | Buy | Maintains | |
2022-03-02 | Piper Sandler | Neutral | Maintains | |
2022-03-02 | Barclays | Equal-Weight | Underweight | Downgrade |
2021-12-16 | Barclays | Equal-Weight | Maintains | |
2021-08-09 | RBC Capital | Sector Perform | Maintains | |
2021-03-03 | Morgan Stanley | Underweight | Maintains | |
2020-11-12 | Morgan Stanley | Underweight | Maintains | |
2020-10-09 | Piper Sandler | Overweight | Maintains | |
2020-04-15 | Piper Sandler | Overweight | Maintains | |
2020-04-02 | Morgan Stanley | Underweight | Maintains | |
2020-01-03 | PiperJaffray | Neutral | Overweight | Upgrade |
2019-07-15 | Morgan Stanley | Equal-Weight | Underweight | Downgrade |
2019-07-11 | RBC Capital | Outperform | Sector Perform | Downgrade |
2019-06-17 | Citi | Buy | Neutral | Downgrade |
2019-06-11 | Barclays | Equal-Weight | Initiate | |
2019-05-13 | JP Morgan | Neutral | Underweight | Downgrade |
2019-03-20 | SunTrust Robinson Humphrey | Buy | Initiate | |
2019-03-18 | JP Morgan | Neutral | Neutral | Maintains |
2019-03-05 | SVB Leerink | Outperform | Market Perform | Downgrade |
2018-11-09 | Canaccord Genuity | Hold | Buy | Upgrade |
2018-10-19 | Cantor Fitzgerald | Neutral | Neutral | Maintains |
2018-09-11 | Goldman Sachs | Sell | Neutral | Upgrade |
2018-08-17 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
2018-08-17 | Canaccord Genuity | Hold | Hold | Maintains |
2018-08-13 | RBC Capital | Sector Perform | Outperform | Upgrade |
2018-08-13 | BMO Capital | Market Perform | Market Perform | Maintains |
2018-08-09 | Stifel Nicolaus | Hold | Hold | Maintains |
2018-08-09 | Citigroup | Buy | Buy | Maintains |
2018-08-07 | B. Riley FBR | Buy | Buy | Maintains |
2018-06-28 | B. Riley FBR | Buy | Buy | Maintains |
2018-06-27 | Citigroup | Neutral | Buy | Upgrade |
2018-04-04 | Mizuho | Buy | Neutral | Downgrade |
2018-03-05 | BMO Capital | Market Perform | Market Perform | Maintains |
2018-02-28 | Gabelli & Co. | Buy | Hold | Downgrade |
2018-02-26 | JMP Securities | Outperform | Market Perform | Downgrade |
2018-02-23 | Barclays | Equal-Weight | Equal-Weight | Maintains |
2018-02-21 | Canaccord Genuity | Hold | Hold | Maintains |
2018-01-03 | Leerink Swann | Outperform | Initiate | |
2017-11-13 | BMO Capital | Market Perform | Maintains | |
2017-11-10 | Citigroup | Neutral | Maintains | |
2017-11-10 | Cantor Fitzgerald | Neutral | Maintains | |
2017-09-28 | Goldman Sachs | Sell | Initiate | |
2017-08-10 | Morgan Stanley | Equal-Weight | Maintains | |
2017-08-09 | Deutsche Bank | Buy | Maintains | |
2017-06-16 | Cantor Fitzgerald | Neutral | Initiate | |
2017-06-09 | Stifel Nicolaus | Buy | Hold | Downgrade |
2017-02-22 | Canaccord Genuity | Buy | Hold | Initiate |
2017-01-20 | JP Morgan | Overweight | Neutral | Downgrade |
2017-01-05 | Citigroup | Buy | Neutral | Downgrade |
2016-11-10 | Susquehanna | Neutral | Positive | Upgrade |
2016-09-29 | Northland Securities | Market Perform | Outperform | Upgrade |
2016-09-16 | Citigroup | Buy | Maintains | |
2016-08-12 | Mizuho | Neutral | Buy | Upgrade |
2016-06-29 | BMO Capital | Market Perform | Initiate | |
2016-06-13 | Mizuho | Underperform | Neutral | Upgrade |
2016-06-06 | Goldman Sachs | Neutral | Initiate | |
2016-05-06 | RBC Capital | Outperform | Sector Perform | Downgrade |
2016-05-06 | PiperJaffray | Overweight | Neutral | Downgrade |
2016-05-06 | Mizuho | Neutral | Underperform | Downgrade |
2016-05-06 | Leerink Swann | Outperform | Market Perform | Downgrade |
2016-04-29 | Citigroup | Buy | Maintains | |
2016-04-21 | JMP Securities | Outperform | Initiate | |
2016-03-21 | JP Morgan | Overweight | Maintains | |
2016-03-21 | Deutsche Bank | Buy | Maintains | |
2016-03-18 | RBC Capital | Top Pick | Outperform | Downgrade |
2016-03-18 | Deutsche Bank | Buy | Maintains | |
2016-03-04 | Nomura | Buy | Maintains | |
2016-03-04 | Barclays | Equal-Weight | Maintains | |
2016-03-01 | Stifel Nicolaus | Buy | Maintains | |
2016-01-21 | Barclays | Equal-Weight | Initiate | |
2015-11-16 | Mizuho | Buy | Neutral | Downgrade |
2015-11-13 | Standpoint Research | Hold | Buy | Upgrade |
2015-11-06 | Leerink Swann | Outperform | Maintains | |
2015-11-06 | Deutsche Bank | Buy | Maintains | |
2015-10-09 | Mizuho | Buy | Initiate | |
2015-10-08 | Mizuho | Buy | Initiate | |
2015-09-29 | Nomura | Buy | Initiate | |
2015-09-29 | Deutsche Bank | Buy | Initiate | |
2015-09-01 | Morgan Stanley | Overweight | Equal-Weight | Downgrade |
2015-08-11 | Leerink Swann | Outperform | Maintains | |
2015-07-17 | RBC Capital | Outperform | Top Pick | Upgrade |
2015-06-15 | Stifel Nicolaus | Buy | Maintains | |
2015-06-03 | Raymond James | Market Perform | Initiate | |
2015-05-21 | JP Morgan | Overweight | Maintains | |
2015-05-12 | Leerink Swann | Outperform | Maintains | |
2015-04-13 | Deutsche Bank | Buy | Maintains | |
2015-03-03 | Keefe Bruyette & Woods | Outperform | Maintains | |
2015-03-03 | Canaccord Genuity | Buy | Maintains | |
2015-02-02 | CRT Capital | Fair Value | Maintains | |
2015-01-30 | Deutsche Bank | Buy | Maintains | |
2014-10-23 | Guggenheim | Buy | Initiate | |
2014-10-13 | Cantor Fitzgerald | Sell | Hold | Upgrade |
2014-09-02 | RBC Capital | Outperform | Initiate | |
2014-07-30 | Cantor Fitzgerald | Sell | Maintains | |
2014-06-27 | Canaccord Genuity | Buy | Initiate | |
2014-06-11 | Wells Fargo | Outperform | Initiate | |
2014-05-05 | Cantor Fitzgerald | Sell | Maintains | |
2014-05-02 | Morgan Stanley | Equal-Weight | Overweight | Upgrade |
2014-05-02 | Leerink Swann | Outperform | Maintains | |
2014-04-30 | National Alliance | Buy | Initiate | |
2014-04-24 | Cantor Fitzgerald | Sell | Maintains | |
2014-04-16 | Sterne Agee | Buy | Initiate | |
2014-03-03 | CRT Capital | Fair Value | Maintains | |
2014-03-03 | Citigroup | Buy | Maintains | |
2014-01-23 | S&P Capital IQ | Sell | Hold | Upgrade |
2014-01-17 | Morgan Stanley | Equal-Weight | Maintains | |
2014-01-02 | Cantor Fitzgerald | Hold | Sell | Downgrade |
2013-11-12 | Citigroup | Buy | Maintains | |
2013-11-06 | PiperJaffray | Underweight | Neutral | Upgrade |
2013-11-06 | Needham | Underperform | Hold | Upgrade |
2013-11-06 | Janney Capital | Sell | Neutral | Upgrade |
2013-11-06 | Cantor Fitzgerald | Sell | Hold | Upgrade |
2013-11-05 | PiperJaffray | Underweight | Neutral | Upgrade |
2013-11-05 | Cowen & Co. | Underperform | Market Perform | Upgrade |
2013-08-08 | Citigroup | Buy | Initiate | |
2013-08-07 | Janney Capital | Neutral | Sell | Downgrade |
2013-07-24 | Morgan Stanley | Equal-Weight | Initiate | |
2013-06-07 | Jefferies | Buy | Maintains | |
2013-06-06 | UBS | Buy | Maintains | |
2013-06-06 | Stifel Nicolaus | Buy | Maintains | |
2013-06-06 | Leerink Swann | Market Perform | Outperform | Upgrade |
2013-06-06 | Cantor Fitzgerald | Hold | Sell | Downgrade |
2013-05-16 | Buckingham Research | Neutral | Buy | Upgrade |
2013-05-13 | Stifel Nicolaus | Buy | Maintains | |
2013-05-13 | Lazard | Neutral | Sell | Downgrade |
2013-05-13 | Jefferies | Buy | Maintains | |
2013-05-08 | Cowen & Co. | Neutral | Underperform | Downgrade |
2013-05-08 | Buckingham Research | Buy | Neutral | Downgrade |
2013-04-17 | Jefferies | Buy | Maintains | |
2013-04-10 | Standpoint Research | Buy | Hold | Downgrade |
2013-04-10 | Janney Capital | Neutral | Initiate | |
2013-02-25 | PiperJaffray | Neutral | Underweight | Downgrade |
2013-02-07 | RBC Capital | Sector Perform | Underperform | Downgrade |
2013-01-31 | Oppenheimer | Outperform | Market Perform | Downgrade |
2013-01-04 | UBS | Buy | Maintains | |
2013-01-04 | Stifel Nicolaus | Buy | Maintains | |
2013-01-04 | PiperJaffray | Overweight | Neutral | Downgrade |
2012-12-27 | JP Morgan | Overweight | Maintains | |
2012-12-14 | Needham | Hold | Underperform | Downgrade |
2012-11-06 | UBS | Buy | Maintains | |
2012-11-06 | Jefferies | Buy | Maintains | |
2012-11-05 | Oppenheimer | Outperform | Maintains | |
2012-10-05 | UBS | Buy | Maintains | |
2012-10-05 | RBC Capital | Outperform | Sector Perform | Downgrade |
2012-10-05 | PiperJaffray | Overweight | Maintains | |
2012-10-05 | Oppenheimer | Outperform | Maintains | |
2012-10-05 | JP Morgan | Overweight | Maintains | |
2012-09-25 | Stifel Nicolaus | Buy | Maintains | |
2012-08-08 | Jefferies | Buy | Maintains | |
2012-08-07 | Oppenheimer | Outperform | Maintains | |
2012-08-06 | Goldman Sachs | Neutral | Maintains | |
2012-05-30 | Stifel Nicolaus | Buy | Maintains | |
2012-05-30 | Cantor Fitzgerald | Hold | Maintains | |
2012-05-30 | Bank oferica | Buy | Maintains | |
2012-05-02 | Cantor Fitzgerald | Hold | Downgrade | |
2012-03-16 | Cantor Fitzgerald | Buy | Initiate |